Publication | Closed Access
Recombinant Human Erythropoietin at High Dose Is Effective for the Treatment of the Anemia of Myelodysplastic Syndromes
13
Citations
0
References
2015
Year
Hematological MalignancyBone Marrow FailureAplastic AnemiaImmunologyHematologyMyelopoiesisRecombinant Human ErythropoietinMedicineMyelodysplastic Syndromes
No additional data available for this publication yet. Check back later!